These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 695155)

  • 21. Drug dosage protocol for calcium oxalate stone.
    Marickar YM; Salim A
    Urol Res; 2009 Dec; 37(6):353-7. PubMed ID: 19826800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies of urinary risk factors in urolithiasis].
    Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y; Minakata S; Yasukawa S; Fukatani T; Ohkawa T
    Hinyokika Kiyo; 1985 Jan; 31(1):1-15. PubMed ID: 3993484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary supersaturation with calcium oxalate before and during orthophosphate therapy.
    Burdette DC; Thomas WC; Finlayson B
    J Urol; 1976 Apr; 115(4):418-22. PubMed ID: 1263318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of pyridoxine supplementation on recurrent stone formers.
    Murthy MS; Farooqui S; Talwar HS; Thind SK; Nath R; Rajendran L; Bapna BC
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):434-7. PubMed ID: 7141762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacotherapy for preventing calcium containing stone formation].
    Nagata M; Takayama T; Mugiya S; Ohzono S
    Clin Calcium; 2011 Oct; 21(10):1530-4. PubMed ID: 21960240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria?
    Robertson WG; Peacock M
    Nephron; 1980; 26(3):105-10. PubMed ID: 7412965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allopurinol treatment for calcium stone disease.
    Br Med J; 1977 Nov; 2(6098):1302-3. PubMed ID: 589161
    [No Abstract]   [Full Text] [Related]  

  • 29. The variability and dietary dependence of urinary oxalate excretion in recurrent calcium stone formers.
    Brown JM; Stratmann G; Cowley DM; Mottram BM; Chalmers AH
    Ann Clin Biochem; 1987 Jul; 24 ( Pt 4)():385-90. PubMed ID: 3662388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of oxalate and calcium oxalate activity and formation product ratio in patients with renal stones before and during treatment.
    Peña JC; Monforte MF; Briceño A
    J Urol; 1987 Nov; 138(5):1137-40. PubMed ID: 3669156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Oxalate stone prophylaxis by alkalinizing therapy (author's transl)].
    Butz M
    Urologe A; 1982 May; 21(3):142-6. PubMed ID: 7048691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute acid load in recurrent oxalate stone formers.
    Knispel HH; Fitzner R; Kaiser M; Butz M
    Urol Int; 1988; 43(2):93-6. PubMed ID: 3388639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Change in inhibitory potential in urine of hyperuricosuric calcium oxalate stone formers effected by allopurinol and orthophosphates.
    Goldwasser B; Sarig S; Azoury R; Wax Y; Hirsch D; Perlberg S; Many M
    J Urol; 1984 Nov; 132(5):1008-11. PubMed ID: 6492268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxalate urolithiasis: significance of serum and urinary oxalate.
    Butz M; Kohlbecker G
    Urol Int; 1980; 35(4):303-8. PubMed ID: 7394936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [What foods should stone formers avoid?].
    Amasaki N; Kurita T
    Hinyokika Kiyo; 2004 Aug; 50(8):573-5. PubMed ID: 15471079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of urinary oxalate by combined calcium and citrate administration without increase in urinary calcium oxalate stone formers.
    Ito H; Suzuki F; Yamaguchi K; Nishikawa Y; Kotake T
    Clin Nephrol; 1992 Jan; 37(1):14-8. PubMed ID: 1541059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of calcium treatment on urinary stone index after intestinal bypass for obesity.
    Holm CN; Hessov I
    Digestion; 1981; 22(5):255-8. PubMed ID: 7308596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of verapamil on urinary stone-forming risk factors.
    Sarica K; Erturhan S; Altay B
    Urol Res; 2007 Feb; 35(1):23-7. PubMed ID: 17165082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory activity of whole urine: a comparison of urines from stone formers and healthy subjects.
    Ryall RL; Hibberd CM; Mazzachi BC; Marshall VR
    Clin Chim Acta; 1986 Jan; 154(1):59-67. PubMed ID: 3943225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Renal oxalate excretion following oral oxalate load in patients with urinary calculus disease and healthy controls].
    Ebisuno S; Morimoto S; Yoshida T; Fukatani T; Yasukawa S; Okawa T
    Hinyokika Kiyo; 1986 Dec; 32(12):1773-9. PubMed ID: 3825824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.